What happens after you stop taking Wegovy

Step 1: what your body does in the weeks immediately after your last dose

Semaglutide has a half-life of roughly a week, which means it takes around five weeks to clear to negligible levels after your final injection. During that time, the GLP-1 receptor activity that slowed gastric emptying and blunted appetite winds down progressively. You may not notice a dramatic change in the first fortnight, but most people find that by week four or five, hunger feels noticeably stronger again.

The physiology here is worth understanding plainly. Obesity involves long-term changes to appetite-regulating hormones (ghrelin, leptin and others) and GLP-1 medicines work by acting on those systems from outside. When the medicine stops, those underlying hormonal patterns reassert themselves. Wegovy's mechanism as a GLP-1 receptor agonist is well described on our treatment overview page if you want the fuller picture.

This is also the period when the temptation to snack later in the evening, eat larger portions, or return to pre-treatment habits tends to reappear. That's not a character flaw; it's a measurable shift in the signals your brain is receiving. Recognising it as such makes it easier to prepare for.

Step 2: the weight-regain curve and what the trial data actually shows

The STEP 1 extension study, published in the New England Journal of Medicine, followed participants for a year after they stopped semaglutide 2.4mg. On average, two-thirds of the weight lost during treatment was regained within 12 months of stopping, and cardiometabolic improvements in blood pressure, blood sugar and cholesterol also partially reversed. The pattern held broadly across participants regardless of how much weight they had lost during treatment.

That figure gets quoted in a way that can feel alarming. It helps to see it in context. Participants in the extension received no additional medical support and no structured behavioural programme during that follow-up year — essentially a cold stop. People who maintain regular contact with a clinician, continue to work on portion awareness and physical activity, and keep some form of accountability tend to do better, though the honest message from the data is that the medicine was doing significant work that lifestyle changes alone cannot fully replace.

For people considering the cost implications of longer-term treatment, our Wegovy price comparison page gives a clear breakdown of what private prescriptions typically involve in the UK.

Step 3: what actually reduces the amount of weight that comes back

Several factors meaningfully affect the trajectory after stopping. Protein intake is the most practically controllable: maintaining adequate protein (many clinicians suggest around 1.2–1.6 g per kg of body weight daily, though your own prescriber will guide the specifics) helps preserve muscle mass, which supports a healthier metabolic rate. Muscle lost during rapid weight reduction is one of the quieter contributors to later regain.

Structured physical activity, particularly resistance exercise, has a similar protective effect on muscle mass and helps anchor the metabolic improvements made during treatment. The NHS's patient information for semaglutide recommends continuing dietary and activity changes as the foundation of any weight management plan.

Consistency with meals matters too. Returning to frequent, unplanned snacking is the most common early driver of weight regain, and setting a loose meal rhythm, particularly in the first month after stopping, helps the body adjust without a sharp caloric overshoot. Think of it like the 12pm dispatch cut-off for our pharmacy orders: a simple structure that removes the need to make the same decision repeatedly.

Some people also find that planned breaks from treatment (rather than permanent discontinuation) work better medically and practically than stopping outright. That decision belongs with your prescriber, not to a self-assessment.

Step 4: when and how to talk to a clinician about what comes next

Stopping Wegovy without a conversation with whoever prescribed it is rarely the best approach. Whether you are pausing due to side effects, reassessing costs, or feeling you have reached a stable weight, the same questions apply: what's the plan for the transition period, what monitoring is appropriate, and what does the evidence suggest about your longer-term risk of regain given your starting profile?

If you are considering what life after Wegovy involves more broadly, or thinking about the timeline of changes when you stop, those pages go into more detail on specific aspects. People who stopped treatment and want to restart, or who are exploring options for the first time, can check their eligibility for a free consultation with one of our GPhC-registered prescribers, who reviews every case personally on the day it's submitted.

The weight management treatment overview covers the licensed options available in the UK if you are weighing up whether a different approach might suit you better going forward. If you want to read more about what happens to your body after you stop taking Wegovy, including the hormonal and metabolic changes involved, or you have questions about what happens if you stop Wegovy part way through treatment, both pages cover those topics in detail.